2Voland C, Serre C M, Delmas P. Plateletoste osarcorna cell interaction is mediated through a specific fibrinogen binding sequence located within the N-terminal domain of thrombospondinl[J]. J Bone Miner Res, 2000,15:361.
3郁知非.临床血液学最近进展[M].广州:暨南大学出版社,1992.
4Stolpe A, Jacobs N, Hage W J, et al. Fibrinogen binding to ICAM21 onEA. hy 926 endothelial cells is dependent on an intact cytoskeleton[J]. Thromb Haemost, 1996,75:182-189.
5Biggerstaff J P, Eth N, Amirkhosravi A, et al. Soluble fibrin augments platelettumor cell adherence in vitro and in vivo, and enhances experimental metastasis[J]. Clin Exp Metastasis, 1999,17:723-730.
6[1]Voland C, Serre CM, Delmas P. Platelet-osteosarcoma cell interaction is mediated through a specific fibrinogen-binding sequence located within the N-terminal domain of thrombospondin 1. J Bone Miner Res, 2000,15:361
7[7]Stolpe A, Jacobs N, Hage W J, et al. Fibrinogen binding to ICAM-1 on EA. hy 926 endothelial cells is dependent on an intact cytoskeleton. Thromb Haemost, 1996,75:182
8Voland C,Serre CM,Delmas P.Platelet-osteosarcoma cell interaction is mediated through a specific fibrinogen-binding sequence located within the N-terminal domain of thrombospondin 1.J Bone Miner Res,2000,15(2):361.
9Gouin-Thibault I.Samama MM.Laboratory diagnosis of the thrombophilic state in cancer patients.Semin Thromb Hemost,1999,25:167～172.
10Yoshida T,Osato H,Sakon M,et al.Locoregianal injec-tion of OK -432/fibrinogen/thrombin for unresevtable metastatic liver tumors.Gan To Kagaku Ryoho,1996,23(11):1575～1577.
